Serum Thyroid Stimulating Hormone Levels Are Associated with the Presence of Coronary Atherosclerosis in Healthy Postmenopausal Women
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Menopause is a natural aging process causing estrogen deficiency, accelerating atherogenic processes including dyslipidemia. Prevalence of thyroid dysfunction is also high in postmenopausal women, and it is known to elevate the risk of cardiovascular disease (CVD). Therefore, we are to study on the associations in between serum thyroid stimulating hormone (TSH) and prevalence of CVD in postmenopausal women who have normal thyroid function.Methods: We performed a retrospective review of 247 Korean postmenopausal women who visited the health promotion center from January, 2007 to December, 2009. Postmenopausal women with normal serum TSH were included in the study. Coronary atherosclerosis was assessed by 64-row multidetector computed tomography. Results: In multiple linear regression analysis, serum TSH was associated with serum triglyceride (TG) (β = 0.146, P = 0.023). In multiple logistic regression analysis, increasing age and serum TSH were associated with an increased risk of coronary atherosclerosis in euthyroid postmenopausal women (odds ratio [OR] = 1.107 [1.024-1.197], P = 0.011 and OR = 1.303 [1.024-1.658], P = 0.031, respectively).Conclusions: It revealed that significant predictor of serum TSH was serum TG, and increasing age and TSH were found to have associations with an increased risk of coronary atherosclerosis in euthyroid postmenopausal women. Screening and assessing risks for CVD in healthy postmenopausal women would be helpful before atherosclerosis develops. (J Menopausal Med 2016;22:146-153)
Abstract
Objectives: Menopause is a natural aging process causing estrogen deficiency, accelerating atherogenic processes including dyslipidemia. Prevalence of thyroid dysfunction is also high in postmenopausal women, and it is known to elevate the risk of cardiovascular disease (CVD). Therefore, we are to study on the associations in between serum thyroid stimulating hormone (TSH) and prevalence of CVD in postmenopausal women who have normal thyroid function.Methods: We performed a retrospective review of 247 Korean postmenopausal women who visited the health promotion center from January, 2007 to December, 2009. Postmenopausal women with normal serum TSH were included in the study. Coronary atherosclerosis was assessed by 64-row multidetector computed tomography. Results: In multiple linear regression analysis, serum TSH was associated with serum triglyceride (TG) (β = 0.146, P = 0.023). In multiple logistic regression analysis, increasing age and serum TSH were associated with an increased risk of coronary atherosclerosis in euthyroid postmenopausal women (odds ratio [OR] = 1.107 [1.024-1.197], P = 0.011 and OR = 1.303 [1.024-1.658], P = 0.031, respectively).Conclusions: It revealed that significant predictor of serum TSH was serum TG, and increasing age and TSH were found to have associations with an increased risk of coronary atherosclerosis in euthyroid postmenopausal women. Screening and assessing risks for CVD in healthy postmenopausal women would be helpful before atherosclerosis develops. (J Menopausal Med 2016;22:146-153)
참고문헌 (38)
- Creatsas G, "Cardiovascular disease: screening and management of the a-symptomatic high-risk post-menopausal woman", Maturitas, 52(Suppl 1), pp.S32~S37 (2005)
- Klein I, "Thyroid hormone and the cardiovascular system", N Engl J Med, 344, pp.501~509 (2001)
- Park HT, "Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women", Maturitas, 62, pp.301~305 (2009)
- Witteman JC, "Increased risk of atherosclerosis in women after the menopause", BMJ, 298, pp.642~644 (1989)
- 이순신, "Application of Bioactive Natural Materials-based Products on Five Women’s Diseases", 대한폐경학회지, 21(3), pp.121~125 (2015), 대한폐경학회
- Salpeter SR, "Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis", J Gen Intern Med, 21, pp.363~366 (2006)
- Rossouw JE, "Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause", JAMA, 297, pp.1465~1477 (2007)
- Barton M, "Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits?", Arterioscler Thromb Vasc Biol, 27, pp.1669~1672 (2007)
- Dworatzek E, "Sex differences in exercise-induced physiological myocardial hypertrophy are modulated by oestrogen receptor beta", Cardiovasc Res, 102, pp.418~428 (2014)
- 구윤희, "폐경여성의 호르몬 치료가 사망률에 미치는 영향", 대한폐경학회지, 18(3), pp.133~138 (2012), 대한폐경학회
- Kawsar Ahmed, "Assessment of Menopausal Symptoms among Early and Late Menopausal Midlife Bangladeshi Women and Their Impact on the Quality of Life", 대한폐경학회지, 22(1), pp.39~46 (2016), 대한폐경학회
- Lambrinoudaki I, "High normal thyroid-stimulating hormone is associated with arterial stiffness in healthy postmenopausal women", J Hypertens, 30, pp.592~599 (2012)
- Ladenson PW, "American thyroid association guidelines for detection of thyroid dysfunction", Arch Intern Med, 160, pp.1573~1575 (2000)
- Baskin HJ, "American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism", Endocr Pract, 8, pp.457~469 (2002)
- González-Rodríguez LA, "Thyroid dysfunction in an adult female population: A population-based study of Latin American Vertebral Osteoporosis Study (LAVOS) - Puerto Rico site", P R Health Sci J, 32, pp.57~62 (2013)
- Sowers M, "Thyroid stimulating hormone (TSH) concentrations and menopausal status in women at the mid-life: SWAN", Clin Endocrinol, 58, pp.340~347 (2003)
- Redmond GP, "Thyroid dysfunction and women's reproductive health", Thyroid, 14(Suppl 1), pp.S5~S15 (2004)
- Rotondi M, "Thyroid and obesity: not a one-way interaction", J Clin Endocrinol Metab, 96, pp.344~346 (2011)
- Walsh JP, "Subclinical thyroid dysfunction as a risk factor for cardiovascular disease", Arch Intern Med, 165, pp.2467~2472 (2005)
- Razvi S, "The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort", J Clin Endocrinol Metab, 95, pp.1734~1740 (2010)
- Klein I, "Thyroid hormone and the cardiovascular system", Am J Med, 88, pp.631~637 (1990)
- Dillmann WH, "Biochemical basis of thyroid hormone action in the heart", Am J Med, 88, pp.626~630 (1990)
- Polikar R, "The thyroid and the heart", Circulation, 87, pp.1435~1441 (1993)
- Park KW, "The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries", Anesth Analg, 85, pp.734~738 (1997)
- Ojamaa K, "Acute effects of thyroid hormone on vascular smooth muscle", Thyroid, 6, pp.505~512 (1996)
- Braverman LE, "Werner & Ingbar's the thyroid: a fundamental and clinical text" (2000), Lippincott Williams & Wilkins
- Resnick LM, "PLasma renin activity in syndromes of thyroid hormone excess and deficiency", Life Sci, 30, pp.585~586 (1982)
- Kiss E, "Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation", Circ Res, 75, pp.245~251 (1994)
- Crowley WF, Jr., "Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement", N Engl J Med, 296, pp.1~6 (1977)
- Bengel FM, "Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging", J Clin Endocrinol Metab, 85, pp.1822~1827 (2000)
- Hak AE, "Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study", Ann Intern Med, 132, pp.270~278 (2000)
- Ruhla S, "A high normal TSH is associated with the metabolic syndrome", Clin Endocrinol, 72, pp.696~701 (2010)
- Gumieniak O, "Thyroid function and blood pressure homeostasis in euthyroid subjects", J Clin Endocrinol Metab, 89, pp.3455~3461 (2004)
- Asvold BO, "Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study", J Clin Endocrinol Metab, 92, pp.841~845 (2007)
- Liu D, "A cross-sectional survey of relationship between serum TSH level and blood pressure", J Hum Hypertens, 24, pp.134~138 (2010)
- Tatar E, "The association between thyroid hormones and arterial stiffness in peritoneal dialysis patients", Int Urol Nephrol, 44, pp.601~606 (2012)
- Desideri G, "Enhanced proatherogenic inflammation after recombinant human TSH administration in patients monitored for thyroid cancer remnant", Clin Endocrinol, 71, pp.429~433 (2009)
- Dardano A, "Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma", J Clin Endocrinol Metab, 91, pp.4175~4178 (2006)